Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
RARE
Ultragenyx Pharmaceutical Inc.
NASDAQ · Pharmaceutical Preparations
Last close
$15.03
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$1.48B
RECENT INSIDER TRADES
2026-09-15
· Huizenga Theodore Alan
(SVP, Chief Accounting Officer)
· SELL
2026-09-08
· Huizenga Theodore Alan
(SVP, Chief Accounting Officer)
· SELL
2026-08-04
· Horn Howard
(Chief Financial Officer)
· SELL
2026-08-04
· Parschauer Karah Herdman
(EVP and Chief Legal Officer)
· SELL
2026-07-06
· Horn Howard
(Chief Financial Officer)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
335
Shares held
124,842,707
Value
$3.97B
Percent of shares outstanding
126.63%
As of quarter end
2026-06-30
RECENT NEWS
Ultragenyx sells rare pediatric disease priority review voucher for $210 million
RARE: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
Ultragenyx Pharmaceutical wins FDA approval for FAYUVI to treat Sanfilippo Syndrome Type A
Ultragenyx Pharmaceutical Inc. · 8-K (8.01)
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Ultragenyx Pharmaceutical Inc. (RARE) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit